Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1542-2018Class III

Alere iScreen Dx Urine Drug Screen Card

Ameditech, Inc. / initiated 2017-12-15 / Terminated / root cause: labeling and UDI

Ameditech Inc began a recall of Alere iScreen Dx Urine Drug Screen Card on . FDA classified it as Class III and gives the reason as "The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1542-2018
Classification
Class III
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Ameditech, Inc.
Product
Alere iScreen Dx Urine Drug Screen Card
Product code
LFH U.V. Spectrometry, Tricyclic Antidepressant Drugs
Reason for recall
The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box.
Root cause tag
labeling and UDI
FDA root cause
Labeling Change Control
Action
Customers were notified on about 12/15/2017. Instructions included to become aware of the recall so as to relay the information to customers with questions.
Quantity in commerce
828 kits (20,700 devices)
Distribution
Distributed domestically to AZ, FL, IL, ND, NV, PA, TN, TX, VA.
Product codes and lots
Part No. X11-IS10-Dx, Lot No. 173351, 173686, 174055, 176002.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1542-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1542-2018Class IIITerminatedVoluntary: Firm initiated